Tandem Diabetes Care TNDM
NASDAQ TNDM
$22.87 -0.59 (-2.51%)
At close: Aug 20, 2026 · 11:17 AM UTC

Tandem Diabetes Care (TNDM) Non Operating Investment Income (2014)

Tandem Diabetes Care's (TNDM) quarterly Non Operating Investment Income came in at $6529.0 in Q3 2014, up 520.95% on a QoQ basis from -$1551.0 in Q2 2014.

Tandem Diabetes Care (TNDM) Non Operating Investment Income (2014) Analysis & Trends

Tandem Diabetes Care (TNDM) has 1 years of Non Operating Investment Income data on file, last reported at $6529.0 in Q3 2014.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Investment Income (Qtr)
1 Abbott Laboratories 200.20 Bn 194.60 Bn 7.27 Bn -
2 Stryker 129.69 Bn 126.21 Bn 4.50 Bn -
3 Medtronic 120.14 Bn 110.92 Bn 6.41 Bn -
4 Boston Scientific 74.16 Bn 73.62 Bn 3.85 Bn -
5 Edwards Lifesciences 52.68 Bn 48.43 Bn 1.35 Bn -
6 Dexcom 34.57 Bn 32.62 Bn 830.00 Mn -
7 GE HealthCare Technologies 34.09 Bn 31.98 Bn 2.18 Bn -
8 Koninklijke Philips 26.49 Bn 23.17 Bn 4.55 Bn -
9 Steris 23.19 Bn 22.70 Bn 684.20 Mn -
10 Tandem Diabetes Care 1.58 Bn 1.13 Bn 144.78 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2014 6,529.00
Sep 30, 2014 6,529.00
Jun 30, 2014 -1,551.00
Jun 30, 2014 -1,551.00
Mar 31, 2014 13,833.00
Mar 31, 2014 13,833.00